Discovery and verification of protein differences between Er positive/Her2/neu negative breast tumor tissue and matched adjacent normal breast tissue

By Weitzel Lindsay-Rae  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 297-305

Springer Publishing Company

Access to resources Recommend Favorite

Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells

By Youngren Jack  

Breast Cancer Research and Treatment, Vol. 94, Iss. 1, 2005-11 ,pp. : 37-46

Springer Publishing Company

Access to resources Recommend Favorite

Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer

By Buzdar A.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 161-175

Springer Publishing Company

Access to resources Recommend Favorite

Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2549-2559

Spandidos Publications

Access to resources Recommend Favorite

Her-2/ neu and Topoisomerase iiα in Breast Cancer

By Järvinen T.A.H.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 3, 2003-04 ,pp. : 299-311

Springer Publishing Company

Access to resources Recommend Favorite